Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Sep 18;69(10):e20230397.
doi: 10.1590/1806-9282.20230397. eCollection 2023.

Cytogenetic changes in oral mucosal cells of human immunodeficiency virus-infected children and adolescents undergoing antiretroviral treatment

Affiliations
Randomized Controlled Trial

Cytogenetic changes in oral mucosal cells of human immunodeficiency virus-infected children and adolescents undergoing antiretroviral treatment

Maria Esther Suarez Alpire et al. Rev Assoc Med Bras (1992). .

Abstract

Objective: The objective of this study was to evaluate possible cytogenetic changes in children and adolescents with human immunodeficiency virus on antiretroviral therapy, through the micronucleus test in oral mucosa.

Methods: This was a prospective study consisted of 40 individuals, of whom 21 comprised the human immunodeficiency virus group and 19 comprised the control group. Children and adolescents with human immunodeficiency virus were enrolled. The inclusion criteria were <18 years old and consent in participating in the study. The exclusion criteria were the presence of numerous systemic comorbidities, oral lesions, the habit of smoking, alcohol consumption, and X-rays or CT scans taken within 15 days prior to sample collection. A gentle scraping was performed on the inner portion of the jugal mucosa on both sides. A total of 2,000 cells per slide were analyzed for the determination of mutagenicity parameters as follows: micronuclei, binucleation, and nuclear buds. For measuring cytotoxicity, the following metanuclear changes were evaluated: pyknosis, karyolysis, and karyorrhexis, in a double-blind manner. The repair index was also evaluated in this setting.

Results: The human immunodeficiency virus group showed high frequencies of micronuclei (p=0.05), binucleated cells (p=0.001), and nuclear buds (p=0.03). In the cytotoxicity parameters, represented by the cell death phases, there was an increase with statistical difference (p≤0.05) in the karyorrhexis frequency (p=0.05). Additionally, repair index was decreased in the human immunodeficiency virus group.

Conclusion: These results indicate that human immunodeficiency virus -infected individuals undergoing antiretroviral therapy have cytogenetic changes in oral mucosal cells.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: the authors declare there is no conflicts of interest.

References

    1. Borges JMC, Pinto JÁ, Ricas J. Crianças e adolescentes vivendo com HIV/aids: “que doença é essa?”. [[cited on Feb 23, 2022]];Reverso, Belo Horizonte. 37:67–73. Available from: http://pepsic.bvsalud.org/scielo.php?script=sci_arttext&pid=S0102-739520... .
    1. Ministério da Saúde. Secretaria de vigilância em saúde. boletim epidemiológico especial. Dez.2020. 68p. Boletim Epidemiológico HIV/Aids 2021 | Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. [[cited on Mar 03, 2022]]. Available from: http://www.aids.gov.br/pt-br/pub/2021/boletim-epidemiologico-hivaids-2021 .
    1. Nance RM, Delaney JAC, Simoni JM, Wilson IB, Mayer KH, Whitney BM, et al. HIV viral suppression trends over time among hiv-infected patients receiving care in the United States, 1997 to 2015: a cohort study. Ann Intern Med. 2018;169(6):376–84. doi: 10.7326/M17-2242. - DOI - PMC - PubMed
    1. Portilla-Tamarit J, Reus S, Portilla I, Fuster Ruiz-de-Apodaca MJ, Portilla J. Impact of advanced HIV disease on quality of life and mortality in the era of combined antiretroviral treatment. J Clin Med. 2021;10(4):716. doi: 10.3390/jcm10040716. - DOI - PMC - PubMed
    1. Aboulker JP, Babiker A, Chaix ML, Compagnucci A, Darbyshire J, Debré M, et al. Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome. AIDS. 2004;18(2):237–45. doi: 10.1097/00002030-200401230-00013. - DOI - PubMed

Publication types

Substances